| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.001 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |